申请人:ZILENTIN AG
公开号:US20210022978A1
公开(公告)日:2021-01-28
The present invention relates to bumetanide derivatives of formula (I) as well as pharmaceutical compositions comprising these compounds for use in the treatment or prevention of diseases/disorders involving Na
+
—K
+
2Cl
−
-cotransporters (NKCCs), and particularly for use in the treatment or prevention of hyperhidrosis.